The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
its was a well timed share offer. The next set of results should be out any day and if they are positive then the share price will spike and no one will have notice that new shares were created. Clever stuff and $250million raised in a day. Impressive.
A lot has moved on from 40 years ago. very high THC strains did not exist 40 years ago. Varieties were much more in balance 40 years ago in terms of THC and CBD ratios. I think the legalisation across the world is foolhardy as much more research should go into the effects of high THC strains before we legalise in the UK. The world is moving on, THC strains are getting stronger. Lets just be careful. Whats a few more years.
No lets delay it until we have more data on the actual historical impact of legalisation in the US. The states are real time experiment - lets use them and see what happens there before we rush in. No point in being a leader in someting that we might regret later. We can then way up the pro's and con's and make an informed decision based on the actual impact in the US. There is no need to rush into this. Get this right and it will work very well.Get this wrong and we will have an expensive mess to sort out. Lets just take our time and see what affects legalisation has on the US. I don't believe studies on high THC trials are corrupt - they just don't help the pro-legalisation argument. We need lots more studies worldwide before we should make a move. The fact is herbal medicine is less tightly controlled than pharmaceutical drugs. I doubt the QA rules would be anywhere near as stringent for herbal medicines. We know that how you grow cannabis can effect concentrations of THC / CBD so how are the herbal guys going to be able to say that each batch they sell is consistent? For administering to sick people and kids this could be trickey.
I think governments advocating, at this stage, full scale legalisation of cannabis are foolhardy. The world already has its biggest scale cannabis trial going on - all the States in the US that have legalised cannabis wholesale. Lets sit back 15-20 years and wait to see what all the effects are. Yes tax money that is raised is a real plus point, but lets wait and see if there are any costs attached to that. We don't know yet and its too early to come to any long term conclusions from the US. I'm pro cannabis leglisation - if its proven to be 100% safe with no attributable major side affects. The US has form on legalising things wholesale to a position that it can't go back - look at gun control. I believe the facts too and FDA clinical trial results on a controlled production of cannabis is a pretty hard fact. Results on medical / herbal cannabis is always going to be more unreliable. I don't understand what you point is with the GWP42004 trials. This is science. Its shows that in a controlled environment things don't always go the way you want it to. GW has had lots of up and downs - this is no miracle company - its been a long time coming. Cannabis has been around for 1,000's of years but GW is the first company to carry out proper clinical trials - its never going to be plain sailing. Just cos something failed once doesn't mean it will fail again - you've just got to try a difference approach. Maybe investors know what the different approach is. I think the shares are doing well because the next set of trial results are to come out soon. If they spike up like they have been about 6.15 then I'm a happy man and my summer holiday is paid for.
E&F, I agree with your sentiment. You have to remember that a lot pf people on this board are pro-medicinal cannabis and not particularly fond of big pharma. I'm a firm believer that the two can sit comfortably side by side, as both have very different markets and strengths So the GW share sale is viewed as negative by the pro-medicinal contingent, whereas I see GW's ability to raise $250 dollars in a day as pretty amazing. If GW invest that cash well, GW can do great things. They must have a few tricks up their sleeves to raise that kind of cash so fast. As a MD of a SME trying to raise £7m in this financial climate of the past 5 years has been eye wateringly difficult. I think once a few more clinical results come out the share price will be close to £8-£10 a share anyway. But we should be prepared for more fund raising from GW going forward until the money starts rolling in from Epiodlex. I view medicinal cannabis as herbal medicine - it certainly works but its not backed up by expensive clinical research and the products do not come with such stringent quality assurance compared to pharmaceutical products. So there is a massive market for medicinal cannabis which be self-treated the majority of the time.Whereas Drs will want proper pharmaceutical drugs for very sick patients. The market for this is big too. Although the pro-medicinal lobby dislike GW - they are actually doing the pro-medicinal lobby a massive favour. GW are demonstrating the clinical effectiveness of Cannabis cannabanoids, which the pro-medicial lobby will ride on the back off. What GW are doing in the medicinal world is ground breaking and their cash is helping indirectly the pro-cannabis lobby that hates GW! Its an interesting world in which we live in! Live and Let Live. Without this cash raising GW would go bust and the ground breaking clinical trials (which are indirectly helping the pro-cannabis lobby) would stop. I don't think GW have much choice and I think they are mighty impressive in what they are doing cash wise and product wise. This is a company to watch. Oh and I brought over £10K at £6.15 the day before GW sold more shares - so I should be bitter. LOL. I just see potential
I agree with you sentiment Reddrag. GW are burning through a ****load of cash. They need to keep raising cash until Epidiolex starts returning income. Bit a of bugger GW do this though just after I brought a wad of shares at 6.14 yesterday though. I'm hoping that the results due anyday with go up between 7.00 and 9.00 so I can make some holiday money Lol
I thought that Guardian article was a great read. Its basically what I have been saying on this forum - indoor cannabis growing makes no logical sense once it is legalised. Cost of production will be so much lower. So outdoor growing or sun growing as this hippie calls it makes absolute sense from a commercial and environmental prespective . It will also push down the price of the cannabis eventually. Also inteesting to see the famracaies are now testimng for pesticide resudue's. There will have to come bascially food safety type legliosation on cannabis crops to pomote safe practise. Again I mentioned this before. If cannabis ever gets legalised across the US and cannabis is allowed to be moved across boarders then production will take place in Florida or California all year round or where its warm and sunny all year round. It will demolish small time growers like this guy. Indoors growers will also disappear. Eventually there will be big firms supplying the 'brands' and the small hickie hippy growers will supply niche pharmacies with niche varieties to satisfy the affectionado. The whole legalization of the US is really fascinating. I think we should hold back for at least 10-20 years and learn from the US before we legalise here in the UK or Europe. Lets learn from others mistakes. There is no rush.
Yep interesting development. I see its use being strictly controlled by pharmacies and prescriptions as a good thing too.
Well I've been involved in both organics and conventional growing. I would say that certainly in the UK and Europe conventional growers are being forced to grow almost without pesticides anyway, as the availability of pesticides gets slowly reduced. Of course in organics you can still use pesticides as long as they are organically produced, and some of these are really nasty. True organic growers don't believe in growing out of the soil and from what I have seen a lot of the US growing models are based on growing in bags etc. Also true organic growers don't believe in hydroponics either. Anything grown out of the soil and in an enclosed system will, to a degree, be hydroponic. So CEO Arsenault is using 'organic' to help differentiate his product as a good marketing tool but I would question if his company is truly organic. Ultimately it will be about proving that a cannabis crop is free of pesticide residues, just like you have to do with food crops. You can do this very effectively without being organic. It's just harder to market!!
The US cannabis industry obliviously is very nervous about GW. Its a threat to them. If GW is a success then the FDA may well not want to legalise cannabis. GW are offering a product that the US cannabis industry does not / cannot provide i.e a FDA approved pharmaceutical drug. I'm sure some parents will want to use Charlotte's Web - it will be cheaper and seen to be more 'wholesome' as it doesn't come from big pharma. But it isn't a pharmaceutical drug - its doesn't ;t have the same regulations to follow and isn't as tightly controlled. I think GW will quickly move into clinical trials of medical issues that Drs will not want to use unregulated and uncontrolled cannabis products for. I think there is a room for both GW and medicinal 'herbal cannabis'. But lets face it, the US cannabis industry isn't really interested in medicinal cannabis. Its helped them get legalisation but the ultimate goal appears to be recreational cannabis. The profits these guys are making is eye watering. It doesn't cost a lot to grow cannabis and the prices they are charging are just insane. The ironic things is the cannabis industry hates GW because its 'big pharma' but the US cannabis industry is making 'big pharma' profits and some. And when you listen to guys like Denis Arsenault, CEO of OrganiGram he wants to be big business. He very much see's the potential. The other thing is if the FDA does ever allow cannabis to be moved across States a lot of these high end facilities will go bust as production moves to warmer climates such as Florida where you could grow all year round with considerably less inputs. So I find the whole US cannabis industry fascinating. There are going to be some big winners and some big losers in the US.
Cramer is talking out of his ass Gw will not be producing painkillers unless they are very expensive pain killers. GW will make it profits on niche high end value pharma. GW will need a load of high end profitable lines before it starts dabbling in such a highly competitive market such as painkillers
This bloke is talking out of his ass GW Pharmaceuticals may not be able to charge premium pricing for Epidiolex because it could conceivably have to compete against high CBD strains of marijuana that are sold through medical marijuana dispensaries. Very sick children in hospital will not be treated in hospital with medical marijuana from a dispensary. GW is supplying a clinical tested product produced to FDA guidelines. Medical Marijuana may have the same make up but it will never comply with FDA guidelines or go through clinical trials.
It would be really interesting to see the link to this piece of imformation! Are they building a manufacturing base in the US as well then?
I think ultimately there has to be some quality standards / regulation put in place - like you do for food crops. A lot of people eat cannabis so its a food crop. Alcohol comes under food standards as well. There has to be some clear regulation - its can't be regulation free. As I have mentioned on here before I think there should be some clear limits on the THC levels available. I think a % of people will always want to grow their own. Its its legal more people will grow less intensively in their own glasshouses and have 1-2 plants for their own consumption. Environmentally this will be much better than the current intensive illegal production - inside under HPS lighting - very inefficient and very high costs in terms of lighting. Holland allows this 1-2 plants legally. I have been in big commercial glasshouses in Holland and spotted two cannabis plants in the corner of the greenhouses. As it is for fruit and veg some people like to know where their plants come from and how they are grown i.e organic. As for availability of varieties I'm sure the Dutch will start a trade in vegetative strains rather than just seeds if cannabis ever becomes legal. This will be a big market for a specialist plant propagator - there are already mail order plant companies. There is no doubt that big growers, where it is legal, will become very proficient in growing cannabis and they will make production cheaper and cheaper. Whether that productivity and cheaper production is passed onto the consumer is a big question. From what I've seen in the US the growers - big or small are making a total **** load of money. Prices should be way below what they are. So to say its 'big' pharma that will rip of the consumer is crap. In the States the small growers and pharmacies are doing a damm fine job of ripping of the public. Once big growers get involved with a more commercial production methods then cost of production will plummet and with competition the quality will get better and better. the small growers are inefficient but are completely ripping off the consumers - the big boys will help to improve efficiencies and reduce prices. But there will always be room for small specialist growers. Look at Chelsea Flower show - all those small plant producers supply via mail order or from their nurseries - hardly any are big scale but they are very specialist (big or usual varieties) and supply the specialist gardener. I think it will be the same for cannabis.
Cramer is full of crap
Never has a post looked so out of date so fast!! GW haven't screwed up the most important scientific study. Seems to me they worked very hard on making sure the placebo effect didn't screw up the results. I doubt the share price will go sub $1 now. Just wait for the next set of results
The bloke is nuts. Seriously. He has just invented a new use of CBD. Nothing to do with the share going up in value